Pharmacyclics

Pharmacyclics, Inc. is an integrated biopharmaceutical company engaged in developing and commercializing therapies for the treatment of cancer and immune-mediated diseases. The Company’s commercial product is IMBRUVICA (ibrutinib), which is an oral, single-agent therapy indicated for the treatment of blood cancer. 
IMBRUVICA (ibrutinib) is a prescription medicine used to treat people with marginal zone lymphoma (MZL) who require a medicine by mouth or injection (systemic therapy) and have received a certain type of prior treatment.

Type
Subsidiary
Parent Company
AbbVie
HQ
Sunnyvale, US
Founded
1991
Pharmacyclics was founded in 1991 and is headquartered in Sunnyvale, US

Pharmacyclics Office Locations

Pharmacyclics has offices in Sunnyvale, South San Francisco, Shanghai and Schaffhausen
Sunnyvale, US (HQ)
999 E Arques Ave
Schaffhausen, CH
36 Mühlentalstrasse
Shanghai, CN
1551 Sichuan N Rd
South San Francisco, US
601 Gateway Blvd

Pharmacyclics Financials and Metrics

Pharmacyclics Summary

Founding Date

1991

Investors

Pharmacyclics is a subsidiary of AbbVie

Pharmacyclics Financials

Pharmacyclics's revenue was reported to be $729.7 m in FY, 2014
USDFY, 2013FY, 2014

Revenue

260.2 m729.7 m

Revenue growth, %

180%

Gross profit

260.2 m

Gross profit Margin, %

100%
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015

Revenue

79.1 m119.4 m113 m207.1 m205.8 m

Cost of goods sold

6.1 m9.3 m11.6 m16.7 m

Gross profit

113.3 m103.7 m195.5 m189.1 m

Gross profit Margin, %

95%92%94%92%
USDFY, 2013FY, 2014

Cash

624 m845 m

Accounts Receivable

11 m64.3 m

Inventories

9.3 m20.6 m

Current Assets

740.8 m1 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015

Cash

548.4 m678.6 m666.3 m724.5 m874.7 m

Accounts Receivable

53.8 m27 m45.3 m53.3 m77 m

Inventories

28.7 m38.3 m41.4 m49 m

Current Assets

624.4 m773 m783.5 m862.9 m1.1 b
USDFY, 2013FY, 2014

Net Income

117.5 m117.5 m

Depreciation and Amortization

595 k595 k

Accounts Payable

1.6 m1.6 m

Cash From Operating Activities

110.7 m110.7 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015

Net Income

42.3 m18.3 m(37.1 m)41.4 m4.1 m
Show all financial metrics

Pharmacyclics Median Salaries

Source: 39 public H-1B filings from Pharmacyclics

Pharmacyclics's Web-traffic and Trends

Pharmacyclics Online and Social Media Presence

Pharmacyclics Company Life and Culture

You may also be interested in